BioSpace News Archive

Eurofins announces that its FDA-authorized At-Home COVID-19 Nasal PCR Test is now being covered by Medicare, Medicaid and commercial insurance providers

AOA’s peer reviewed scientific journal will transition to an online-only, open access publication focused on literature that incorporates an integrative, comprehensive, patient-centered approach to clinical care and health, illustrating the distinctive practice of osteopathic medicine

Benitec Biopharma, Inc. (NASDAQ: BNTC), today announced that its 2020 Annual Meeting of Stockholders will be held virtually on Wednesday December 9, 2020 at 3 p.m. (Pacific Time) . The meeting details and instructions on how to access the virtual meeting are provided below:

Rocket Pharmaceuticals Presents Positive Clinical Data from its Fanconi Anemia and Leukocyte Adhesion Deficiency-I Programs at the 62 nd American Society of Hematology Annual Meeting –Two of Three FA “Process B” Patients with at Least 12-Months Follow-Up and Three of Four Additional Patients with Shorter Follow-Up Demonstrate Evidence of Engraftment— – Follow-Up Data from Phase 1/2 Trial for Leukocyte Adhesion Deficiency-I

The American Academy of Orthopaedic Surgeons invites journalists and print, online and broadcast news outlets to submit content to be considered for the 2021 Media Orthopaedic Reporting Excellence Awards.

StoneBridge Healthcare, LLC (StoneBridge), an innovative company formed to buy, save and turn around distressed hospitals in the cities and suburbs of America, today announced it has presented a Letter of

Kubota Vision Inc. (“Kubota Vision”), a clinical-stage specialty ophthalmology company and wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd. (Tokyo 4596), announced today the submission of novel Vascular Adhesion Protein-1 (VAP-1) inhibitor compounds discovered by Kubota Vision to the U.S. National Cancer Institute (NCI) Developmental Therapeutics Program (DTP) for screening in the NCI-60 Human Tumor Cell Lines

“Lab at your fingertip” technology requiring no additional equipment with pending EUA application delivers 100% sensitivity and 100% specificity in BEI study

Everlywell, a leading digital health company and provider of one of the only FDA-authorized at-home sample collection kits for COVID-19, today announced it has entered into a distribution agreement with diagnostics manufacturer Cellex, the first company to receive an FDA Emergency Use Authorization for a COVID-19 antibody test.

Acuva Technologies Inc. (“Acuva”), today announced successful validation of the Acuva™ SOLARIS handheld disinfecting wand against SARS-CoV-2 (COVID-19).